Abstract:Abstract Introduction The FDA recently cleared the first OSA treatment by oral appliances (mRNA, mmRNA, and DNA, Vivos Therapeutics, Littleton, CO). These appliances are designed to be worn 6-24 months and use slow maxillary expansion (DNA) combined with mandibular advancement (mRNA/mmRNA) to increase upper airway volume and improve OSA. Methods This retrospective analysis used a research database initiated in 2018 incorporating real world data from treating dentists for these devices to September 2023. Database contains pre-/posttreatment (without the oral appliance) AHI, transpalatal width (TPW), airway volume (AV) via cone beam computed tomography, and safety data. Study inclusion criteria were adults with severe OSA (AHI>30), mRNA (includes mmRNA)/DNA treatment, and pre-/posttreatment AHI > 6 months apart; exclusion criterion was no safety data. Co-primary endpoints were pre- to posttreatment AHI and TPW improvement; secondary endpoints were pre- to posttreatment AV improvement and safety measures. Results Seventy-three severe OSA patients (36 mRNA/37 DNA) were compared to 35 moderate OSA patients (12 mRNA/23 DNA). Severe OSA: 38 men/35 women, Age 56.3±10.8years, Treatment Duration 15.6±7.2months, Appliance Adherence 11.9±2.6hours. Moderate OSA: 15 men/20 women, Age 48.9±11.7years, Treatment Duration 13.0±6.0months, Appliance Adherence 12.4±2.5hours. For severe OSA patients, pre-treatment vs. posttreatment AHI, TPW, and AV were found to significantly decrease 46.1±15.1 to 21.7±14.8 (-50.8%, p<.00001), increase 33.2±3.5 to 35.5±3.7mm (+7.2%, p<.00001), and increase 20479±7991 to 23767±9191mm3 (+16.6%, p<.00001), respectively. For moderate OSA patients, pre-treatment vs. posttreatment AHI, TPW, and AV were found to significantly decrease 21.6±4.5 to 12.0±10.5 (-44.4%, p<.00001), increase 32.9±2.8 to 35.1±2.9mm (+6.6%, p<.00001), and increase 21598±6260 to 24364±6033mm3 (+12.8%, p<.005), respectively. Severe OSA patients who wore mRNA and DNA appliances decreased their AHI by 55.6% and 46.2% and reduced their AHI classification by 1 or improved their AHI by 50% were 81% and 78%, respectively. No significant safety issues were observed. Conclusion Historically, oral appliances were indicated for those with mild-moderate OSA; this study showed that severe OSA patients had more improvement in AHI, TPW, and AV vs. those with moderate OSA. Results were slightly better for patients with DNA vs. mRNA, demonstrating that the primary improvement mechanism is maxillary expansion with persistent treatment effects without the appliance in place. Support (if any)

Wearing the mandibular advancement orthosis and dental movements: Contribution of a digital monitoring protocol

Dentoskeletal changes of long‐term oral appliance treatment in patients with obstructive sleep apnea: A systematic review and meta‐analysis

Objectively measured adherence may affect side effects of mandibular advancement therapy in subjects with obstructive sleep apnea

0548 A 5-year Multi-center Real-world Study Evaluating the Effectiveness and Use of CAD/CAM 3D-printed OAT to Treat OSA

[Mandibular advancement devices in patients with severe OSAHS]

Oral appliance influence on jaw function in obstructive sleep apnea

Craniofacial morphological changes induced by a mandibular repositioning oral appliance and their significance

A Systematic Review of Oral Modifications Caused by the Prolonged Application of Continuous Positive Airway Pressure (CPAP) and Intraoral Appliances in Patients with Obstructive Sleep Apnea (OSA)

Oral Appliance Treatment for Obstructive Sleep Apnea: An Update

Dental and Skeletal Changes of Long-term Use of Mandibular Advancement Devices for the Treatment of Adult Obstructive Sleep Apnea: a Systematic Review and Meta-analysis

Role of Craniofacial Phenotypes in the Response to Oral Appliance Therapy for Obstructive Sleep Apnea.

[Three-Dimensional Model Analysis of Obstructive Sleep Apnea Hyponea Syndrome Patients with Long-Term Treatment of Oral Appliances].

The use of oral appliances in obstructive sleep apnea: a retrospective cohort study spanning 14 years of private practice experience

Long-term Therapeutic Efficacy of Oral Appliances in Treatment of Obstructive Sleep Apnea-Hypopnea Syndrome

Diagnostic and Therapeutic Indications of Different Types of Mandibular Advancement Design for Patients with Obstructive Sleep Apnea Syndrome: Indications from Literature Review and Case Descriptions

Effect of mandibular advancement device on the stomatognathic system in patients with mild-to-moderate obstructive sleep apnoea-hypopnoea syndrome

0549 Non-Permanent Oral Appliance Treatment of Severe Obstructive Sleep Apnea

Comparison of dental movements in digital setups created by orthodontists and "3shape design service®" engineers: A cross-sectional study

The Effect Of Gradually Increased Mandibular Advancement On The Efficacy Of An Oral Appliance In The Treatment Of Obstructive Sleep Apnea

Efficacy of a Trial Oral Appliance in OSAS Management: A New Protocol to Recognize Responder/Nonresponder Patients

In-home mandibular repositioning during sleep using MATRx plus predicts outcome and efficacious positioning for oral appliance treatment of obstructive sleep apnea.